Purple Biotech Ltd. (PPBT) Tops Q2 EPS by 1c

Purple Biotech Ltd. (NASDAQ: PPBT) reported Q2 EPS of ($0.25), $0.01 better than the analyst estimate of ($0.26).

For earnings history and earnings-related data on Purple Biotech Ltd. (PPBT) click here.

You May Also Be Interested In

• Synopsys upgraded at Piper Sandler on Intel foundry momentum, Apple opportunity
• Morgan Stanley Starts Adani Enterprises Ltd. (ADE:IN) at Overweight
• BofA lists top 5 themes driving next $1tn in incremental semi sales